Candida infection of the central nervous system following neurosurgery: a 12-year review
暂无分享,去创建一个
[1] F. Fitzpatrick,et al. Candida parapsilosis meningitis associated with Gliadel (BCNU) wafer implants , 2011, British journal of neurosurgery.
[2] F. Sörgel,et al. Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections , 2010, Clinical Microbiology Reviews.
[3] Stacy A. Voils,et al. Candida Meningitis Post Gliadel Wafer Placement Successfully Treated with Intrathecal and Intravenous Amphotericin B , 2010, The Annals of pharmacotherapy.
[4] E. Anaissie,et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] J. Sobel,et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] D. Andes,et al. CNS pharmacokinetics of antifungal agents. , 2007, Expert opinion on drug metabolism & toxicology.
[7] W. Hall,et al. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] C.-H. Lu,et al. Coagulase-Negative Staphylococcal Meningitis in Adults: Clinical Characteristics and Therapeutic Outcomes , 2005, Infection.
[9] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] R. Darouiche,et al. Candida Infections of Medical Devices , 2004, Clinical Microbiology Reviews.
[11] J. Bartlett. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study , 2004 .
[12] P. Brennan,et al. Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement. , 2003, Clinical Infectious Diseases.
[13] Á. Montero,et al. Candida Infection of Cerebrospinal Fluid Shunt Devices: Report of Two Cases and Review of the Literature , 2000, Acta Neurochirurgica.
[14] S. Gordon,et al. Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] V. Yu,et al. Meningitis caused by Candida species: an emerging problem in neurosurgical patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] R. M. Tucker,et al. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis , 1988, Antimicrobial Agents and Chemotherapy.
[17] E. Block,et al. Pharmacological Studies with 5-Fluorocytosine , 1972, Antimicrobial Agents and Chemotherapy.